120 related articles for article (PubMed ID: 1374099)
1. Expression of an exogenous tumor necrosis factor (TNF) gene in TNF-sensitive cell lines confers resistance to TNF-mediated cell lysis.
Vanhaesebroeck B; Decoster E; Van Ostade X; Van Bladel S; Lenaerts A; Van Roy F; Fiers W
J Immunol; 1992 May; 148(9):2785-94. PubMed ID: 1374099
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity in L929 murine fibrosarcoma cells after triggering of transfected human p75 tumour necrosis factor (TNF) receptor is mediated by endogenous murine TNF.
Vercammen D; Vandenabeele P; Declercq W; Van de Craen M; Grooten J; Fiers W
Cytokine; 1995 Jul; 7(5):463-70. PubMed ID: 7578985
[TBL] [Abstract][Full Text] [Related]
3. Two discrete types of tumor necrosis factor-resistant cells derived from the same cell line.
Vanhaesebroeck B; Van Bladel S; Lenaerts A; Suffys P; Beyaert R; Lucas R; Van Roy F; Fiers W
Cancer Res; 1991 May; 51(9):2469-77. PubMed ID: 1849793
[TBL] [Abstract][Full Text] [Related]
4. Constitutive expression of human hsp27, Drosophila hsp27, or human alpha B-crystallin confers resistance to TNF- and oxidative stress-induced cytotoxicity in stably transfected murine L929 fibroblasts.
Mehlen P; Preville X; Chareyron P; Briolay J; Klemenz R; Arrigo AP
J Immunol; 1995 Jan; 154(1):363-74. PubMed ID: 7995955
[TBL] [Abstract][Full Text] [Related]
5. Expression of endogenous tumor necrosis factor as a protective protein against the cytotoxicity of exogenous tumor necrosis factor.
Himeno T; Watanabe N; Yamauchi N; Maeda M; Tsuji Y; Okamoto T; Neda H; Niitsu Y
Cancer Res; 1990 Aug; 50(16):4941-5. PubMed ID: 2379159
[TBL] [Abstract][Full Text] [Related]
6. Expression of the tumor necrosis factor gene in tumor cells correlates with reduced tumorigenicity and reduced invasiveness in vivo.
Vanhaesebroeck B; Mareel M; Van Roy F; Grooten J; Fiers W
Cancer Res; 1991 Apr; 51(8):2229-38. PubMed ID: 2009541
[TBL] [Abstract][Full Text] [Related]
7. Endogenous tumor necrosis factor exerts its protective function intracellularly against the cytotoxicity of exogenous tumor necrosis factor.
Okamoto T; Watanabe N; Yamauchi N; Tsuji Y; Tsuji N; Itoh Y; Neda H; Niitsu Y
Cancer Res; 1992 Oct; 52(19):5278-81. PubMed ID: 1327505
[TBL] [Abstract][Full Text] [Related]
8. Increased sensitivity to MHC-nonrestricted lysis of BL6 melanoma cells by transfection with class I H-2Kb gene.
Gorelik E; Jay G; Kwiatkowski B; Herberman RB
J Immunol; 1990 Sep; 145(5):1621-32. PubMed ID: 2384672
[TBL] [Abstract][Full Text] [Related]
9. Endogenous tumor necrosis factor functions as a resistant factor against hyperthermic cytotoxicity.
Tsuji Y; Watanabe N; Okamoto T; Tsuji N; Sasaki H; Akiyama S; Yamauchi N; Niitsu Y
Cancer Res; 1992 Nov; 52(22):6258-62. PubMed ID: 1423271
[TBL] [Abstract][Full Text] [Related]
10. Effect of bcl-2 proto-oncogene expression on cellular sensitivity to tumor necrosis factor-mediated cytotoxicity.
Vanhaesebroeck B; Reed JC; De Valck D; Grooten J; Miyashita T; Tanaka S; Beyaert R; Van Roy F; Fiers W
Oncogene; 1993 Apr; 8(4):1075-81. PubMed ID: 8455935
[TBL] [Abstract][Full Text] [Related]
11. Selective formation of tumor necrosis factor-alpha (TNF) degradation products contributes to TNF mediated cytotoxicity.
Fruehauf JP; Sinha BK
Oncol Res; 1992; 4(3):91-101. PubMed ID: 1319775
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of resistant human tumor cell lines to tumor necrosis factor and adriamycin used in combination: correlation between down-regulation of tumor necrosis factor-messenger RNA induction and overcoming resistance.
Safrit JT; Bonavida B
Cancer Res; 1992 Dec; 52(23):6630-7. PubMed ID: 1330298
[TBL] [Abstract][Full Text] [Related]
13. Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression.
Zyad A; Bénard J; Tursz T; Clarke R; Chouaib S
Cancer Res; 1994 Feb; 54(3):825-31. PubMed ID: 7905787
[TBL] [Abstract][Full Text] [Related]
14. Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells.
Niiya M; Niiya K; Kiguchi T; Shibakura M; Asaumi N; Shinagawa K; Ishimaru F; Kiura K; Ikeda K; Ueoka H; Tanimoto M
Cancer Chemother Pharmacol; 2003 Nov; 52(5):391-8. PubMed ID: 12908082
[TBL] [Abstract][Full Text] [Related]
15. Hemorrhage induces enhanced Kupffer cell cytotoxicity while decreasing peritoneal or splenic macrophage capacity. Involvement of cell-associated tumor necrosis factor and reactive nitrogen.
Ayala A; Perrin MM; Wang P; Ertel W; Chaudry IH
J Immunol; 1991 Dec; 147(12):4147-54. PubMed ID: 1753090
[TBL] [Abstract][Full Text] [Related]
16. Gene activation mediated by protein kinase C in human macrophage and teratocarcinoma cells expressing aminoglycoside phosphotransferase activity.
Maio JJ; Brown FL
J Cell Physiol; 1991 Dec; 149(3):548-59. PubMed ID: 1660486
[TBL] [Abstract][Full Text] [Related]
17. Sensitization of tumor necrosis factor alpha-resistant human melanoma by tumor-specific in vivo transfer of the gene encoding endothelial monocyte-activating polypeptide II using recombinant vaccinia virus.
Gnant MF; Berger AC; Huang J; Puhlmann M; Wu PC; Merino MJ; Bartlett DL; Alexander HR; Libutti SK
Cancer Res; 1999 Sep; 59(18):4668-74. PubMed ID: 10493523
[TBL] [Abstract][Full Text] [Related]
18. An apoptosis-inducing gene therapy for pancreatic cancer with a combination of 55-kDa tumor necrosis factor (TNF) receptor gene transfection and mutein TNF administration.
Sato T; Yamauchi N; Sasaki H; Takahashi M; Okamoto T; Sakamaki S; Watanabe N; Niitsu Y
Cancer Res; 1998 Apr; 58(8):1677-83. PubMed ID: 9563482
[TBL] [Abstract][Full Text] [Related]
19. Cellular models of macrophage tumoricidal effector mechanisms in vitro. Characterization of cytolytic responses to tumor necrosis factor and nitric oxide pathways in vitro.
Klostergaard J; Leroux ME; Hung MC
J Immunol; 1991 Oct; 147(8):2802-8. PubMed ID: 1918993
[TBL] [Abstract][Full Text] [Related]
20. Divergent effects of H-2K and H-2D genes on sensitivity of BL6 melanoma cells to NK cells or TNF-mediated cytotoxicity.
Kim M; Duty L; Herberman R; Gorelik E
Cell Immunol; 1994 May; 155(2):358-71. PubMed ID: 8181071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
